Brain Vascular Disease in Aging and Dementia

CompletedOBSERVATIONAL
Enrollment

48

Participants

Timeline

Start Date

May 23, 2017

Primary Completion Date

August 31, 2019

Study Completion Date

August 31, 2019

Conditions
Alzheimer DiseaseWhite Matter HyperintensitiesDementiaAging
Interventions
RADIATION

Florbetaben F18

10Meq of Florbetaben F 18 via intravenous injection is to be used. Visit duration is approximately 3 hours.

PROCEDURE

Transcranial Doppler

All participants will undergo Doppler ultrasonography that measures the velocity of blood flow through the brain's blood vessels. Visit duration is approximately 45 minutes and will be scheduled for either the same day or another day as the PET scan.

Trial Locations (1)

10032

Columbia University Medical Center, New York

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

Columbia University

OTHER

NCT03075007 - Brain Vascular Disease in Aging and Dementia | Biotech Hunter | Biotech Hunter